A Double-Blind, Randomised, Dose-Ranging Study to Compare K-832 with Placebo in the treatment of Patients with Active Rheumatoid Arthritis.
Phase of Trial: Phase II
Latest Information Update: 31 May 2011
At a glance
- Drugs K 832 (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 31 May 2011 New trial record